University of California, San Francisco (UCSF) Department of Radiology & Biomedical Imaging and GE HealthCare  announced the launch of a Care Innovation Hub, a joint research collaboration that aims to address meaningful clinical challenges in three key areas: accessibility to advanced medical imaging, non-invasive diagnosis and management of neurological and neurodegenerative disease, and precision oncology. The Care Innovation Hub leverages the strengths of academia and industry to create, evaluate and translate novel technology into a clinical setting with the goals of advancing diagnosis and treatment of disease, improving hospital operations and driving more equitable access to care.

“We’re honored to collaborate with UCSF on this important work, which has the potential to significantly improve patient outcomes and address life-threatening diseases like Alzheimer’s disease and prostate cancer worldwide”

The Care Innovation Hub builds on a decades-long history between UCSF and GE HealthCare, bringing research focus areas under one framework. It integrates the research and clinical expertise of UCSF in critical care areas such as brain health, neurodegenerative disease and oncology, with GE HealthCare’s deep knowledge in research and product development.

“Our collaboration with GE HealthCare brings a practical focus on addressing well-defined clinical objectives,” said Sharmila Majumdar, PhD, Research Vice Chair in the UCSF Department of Radiology & Biomedical Imaging. “Together, we’re accelerating innovation in ways that will improve access to care and outcomes across healthcare settings.”

The Care Innovation Hub centers on three focus areas designed to address impactful clinical goals and answer critical questions in the field of medical imaging and treatment:

• Building an imaging service line of the future
• Advancing solutions for neurodegenerative disease
• Driving Accessible Precision Oncology

“We’re honored to collaborate with UCSF on this important work, which has the potential to significantly improve patient outcomes and address life-threatening diseases like Alzheimer’s disease and prostate cancer worldwide,” said Erin Angel, PhD, GE HealthCare Global Vice President, Research and Scientific Affairs. “By combining our strengths, we’re taking steps toward solutions that meet real clinical needs. Together, we’re building something we hope will make a meaningful difference for patients and the future of healthcare.”